RIPK2 is an unfavorable prognosis marker and a potential therapeutic target in human kidney renal clear cell carcinoma
Diangeng Li, Liangyou Tang, Bo Liu, Shibo Xu, Meiling Jin, Bo Wu
Abstract
. In conclusion, elevated RIPK2 expression indicates a worse prognosis for KIRC patients and could serve as a potential prognostic biomarker and therapeutic target in kidney cancer.
Topics & Concepts
Renal cell carcinomaMedicineKidneyCancer researchKidney cancerInternal medicineOncologyRenal cell carcinoma treatmentFerroptosis and cancer prognosisRenal and related cancers